
Volume 194, Issue 12
15 December 2006
Cover image
Cover image

Microfilament disruption (Texan Red phalloidin), cell rounding, and apoptosis of human monocytes infected with Yersinia pestis (top; uninfected control, bottom) do not prevent T cell responses, which may be assisted by other components of innate immunity that remain intact (TLR9, green). Cells and bacterial DNA were labeled with 4,6-diamindino-2-phenylindole (image by G. Ruthel). (see Saikh et al., on pp. 1753–60).0022
ISSN 0022-1899
EISSN 1537-6613
Issue navigation
Volume 194, Issue 12, 15 December 2006
Editorial Commentaries
Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines
Harriet L. Robinson and Kent J. Weinhold
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1625–1627, https://doi.org/10.1086/509263
Is the Glass Three‐Quarters Full or One‐Quarter Empty?
Justin C. McArthur and Scott L. Letendre
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1628–1631, https://doi.org/10.1086/508755
Immune‐Based Therapy for HIV Infection: Are Acute and Chronic HIV Infection Different Diseases?
Peter W. Hunt and Steven G. Deeks
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1632–1634, https://doi.org/10.1086/509627
Finding the Cause of Kawasaki Disease: A Pediatric Infectious Diseases Research Priority
Anne H. Rowley
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1635–1637, https://doi.org/10.1086/509514
Major Articles and Brief Reports
HIV/AIDS
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus Vector
Andrew T. Catanzaro and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1638–1649, https://doi.org/10.1086/509258
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine
Barney S. Graham and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1650–1660, https://doi.org/10.1086/509259
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
Punnee Pitisuttithum and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1661–1671, https://doi.org/10.1086/508748
A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV‐Specific Immunizations, and Interleukin‐2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024)
J. Michael Kilby and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1672–1676, https://doi.org/10.1086/509508
Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138
Michael M. Lederman and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1677–1685, https://doi.org/10.1086/509261
Treatment Benefit on Cerebrospinal Fluid HIV‐1 Levels in the Setting of Systemic Virological Suppression and Failure
Serena Spudich and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1686–1696, https://doi.org/10.1086/508750
Viruses
Blinded Case‐Control Study of the Relationship between Human Coronavirus NL63 and Kawasaki Syndrome
Samuel R. Dominguez and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1697–1701, https://doi.org/10.1086/509509
Human Papillomavirus Prevalence in Women Who Have and Have Not Undergone Hysterectomies
Philip E. Castle and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1702–1705, https://doi.org/10.1086/509511
Viral Load, E2 Gene Disruption Status, and Lineage of Human Papillomavirus Type 16 Infection in Cervical Neoplasia
Jo L. K. Cheung and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1706–1712, https://doi.org/10.1086/509622
Equal Amounts of Intracellular and Virion‐Enclosed Hepatitis C Virus RNA Are Associated with Peripheral‐Blood Mononuclear Cells In Vivo
Philipp Kaiser and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1713–1723, https://doi.org/10.1086/508431
A Complete Mutational Fitness Map of the Hepatitis C Virus Nonstructural 3 Protease: Relation to Recognition by Cytotoxic T Lymphocytes
Jonas Söderholm and Matti Sällberg
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1724–1728, https://doi.org/10.1086/509513
Reductions in Cross‐Neutralizing Antibody Responses in Infants after Attenuation of the Human Rotavirus Vaccine Candidate 89‐12
Richard L. Ward and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1729–1736, https://doi.org/10.1086/509623
Quantification of Viral Inactivation by Photochemical Treatment with Amotosalen and UV A Light, Using a Novel Polymerase Chain Reaction Inhibition Method with Preamplification
Jean‐Pierre Allain and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1737–1744, https://doi.org/10.1086/509260
Bacteria
Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom
Cressida Auckland and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1745–1752, https://doi.org/10.1086/509619
Human Cytolytic T Cell Recognition of Yersinia pestis Virulence Proteins That Target Innate Immune Responses
Kamal U. Saikh and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1753–1760, https://doi.org/10.1086/509507
Is Panton‐Valentine Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐Resistant Staphylococcus aureus Disease?
Jovanka M. Voyich and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1761–1770, https://doi.org/10.1086/509506
Antibiotic Selection May Contribute to Increases in Macrolide‐Resistant Treponema pallidum
Christina M. Marra and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1771–1773, https://doi.org/10.1086/509512
Uropathogenic Escherichia coli Alters Muscle Contractions in Rat Urinary Bladder via a Nitric Oxide Synthase–Related Signaling Pathway
Te I Weng and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1774–1782, https://doi.org/10.1086/509620
Parasites
Evaluation of Purified Taenia solium Glycoproteins and Recombinant Antigens in the Serologic Detection of Human and Swine Cysticercosis
Marcello Otake Sato and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1783–1790, https://doi.org/10.1086/509262
Correspondence
Increase in Serogroup C Meningococcal Disease in Canada Is Associated with Antigenic Changes in the Protein Antigens of the ET‐15 Clone of Neisseria meningitidis
Raymond S. W. Tsang and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1791–1792, https://doi.org/10.1086/509515
Reply to Tsang et al.
Lee H. Harrison and Martin C. J. Maiden
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1792–1793, https://doi.org/10.1086/509516
Is There a Safe Age for Vaccinating Infants with Tetravalent Rhesus‐Human Reassortant Rotavirus Vaccine?
Paul M. Gargiullo and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1793–1794, https://doi.org/10.1086/509264
Reply to Gargiullo et al.
Kenneth J. Rothman and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1794–1795, https://doi.org/10.1086/509265
Is Human Herpesvirus–6 DNA in Plasma the Right Marker for Active Infection?
Abla Achour and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1795–1796, https://doi.org/10.1086/509624
Reply to Achour et al.
Masao Ogata and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1796–1797, https://doi.org/10.1086/509626
Recurrence of Symptomatic Bacterial Vaginosis 12 Months after Oral Metronidazole Therapy in HIV‐Positive and ‐Negative Women
Landon Myer and others
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1797–1799, https://doi.org/10.1086/509625
Errata
Sandhu et al. (2006; 194:1428-37)
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Page 1800, https://doi.org/10.1086/510194
Anderson et al. (2006; 194:1577-9)
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Page 1800, https://doi.org/10.1086/510318
Reviewers of Volume 194
Reviewers
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1801–1804, https://doi.org/10.1086/510691
Author Index to Volume 194
Author Index
The Journal of Infectious Diseases, Volume 194, Issue 12, 15 December 2006, Pages 1805–1811, https://doi.org/10.1086/512597
Advertisement
Advertisement